Peanut allergy diagnoses among children residing in Olmsted County, Minnesota

Maria Rinaldi1, Lisa Harnack, Charles Oberg

  • 1Department of Epidemiology and Community Health, University of Minnesota, Minneapolis, MN 55454, USA. rinal002@umn.edu

Insights

Peanut allergy diagnoses in children have tripled in Olmsted County, Minnesota, from 1999 to 2007. This trend highlights a growing public health concern for pediatric food allergies.

Area of Science:

  • Epidemiology
  • Pediatric Allergy
  • Public Health

Background:

  • Peanut allergy is a significant health issue, especially in developed nations.
  • Diagnoses have increased threefold over the last two decades, affecting up to 2% of children.

Purpose of the Study:

  • To determine the prevalence and incidence rates of peanut allergy diagnoses in children.
  • Study period: 1999-2007 in Olmsted County, Minnesota.

Main Methods:

  • Population-based descriptive study using the Rochester Epidemiology Project.
  • Medical chart review of 547 potential diagnoses, identifying 244 prevalent and 170 incident cases.
  • Age- and sex-adjusted rates standardized to the 1999 Olmsted County population; Poisson regression for incidence rate ratios.

Main Results:

  • Prevalence in 2007 was 0.65%.
  • Young children (0-2 years) and males had higher diagnosis rates.
  • A significant threefold increase in diagnoses was observed, from 2.05 to 6.88 cases per 10,000 children (1999-2007).

Conclusions:

  • Peanut allergies represent a growing concern in Olmsted County, Minnesota.
  • Diagnosis rates increased threefold between 1999 and 2007.
  • The findings underscore the need for continued monitoring and intervention strategies for pediatric peanut allergies.
Abstract

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

Overview
26.4K
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.6K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.4K
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
280